PDL BioPharma - 28 Year Stock Price History | PDLI

Historical daily share price chart and data for PDL BioPharma since 1992 adjusted for splits. The latest closing stock price for PDL BioPharma as of December 30, 2020 is 2.47.
  • The all-time high PDL BioPharma stock closing price was 15.34 on March 07, 2000.
  • The PDL BioPharma 52-week high stock price is 0.00, which is -100% above the current share price.
  • The PDL BioPharma 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average PDL BioPharma stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
PDL BioPharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.0033 3.2100 3.7400 2.1500 2.4700 -23.88%
2019 3.0441 2.9100 3.8500 2.1250 3.2450 11.90%
2018 2.6808 2.8700 3.1200 2.2800 2.9000 5.84%
2017 2.5926 2.2300 3.5100 1.9800 2.7400 29.25%
2016 3.0789 3.3576 3.7665 1.9800 2.1200 -38.29%
2015 5.3549 6.6576 6.6923 3.3964 3.4352 -48.60%
2014 7.2441 6.9235 8.5975 6.0479 6.6836 -2.32%
2013 6.1253 5.5159 8.0516 4.9974 6.8424 29.33%
2012 4.9576 4.2528 6.1688 4.1494 5.2905 23.80%
2011 3.8330 3.9642 4.3068 2.9233 4.2735 10.05%
2010 3.4647 3.6539 4.0577 2.8763 3.8832 6.58%
2009 3.0852 2.3326 3.8393 2.0863 3.6433 57.96%
2008 2.6615 3.2113 3.3787 1.7472 2.3065 -29.77%
2007 4.0743 3.7643 5.1928 3.0950 3.2844 -13.01%
2006 4.3310 5.3315 6.1488 3.0950 3.7755 -29.13%
2005 4.1844 3.8037 5.6089 2.5964 5.3277 37.56%
2004 3.7524 3.4531 5.0878 2.8307 3.8730 15.42%
2003 2.2839 1.6872 3.5468 1.3085 3.3556 110.59%
2002 2.5183 5.9033 5.9033 1.3872 1.5934 -74.09%
2001 5.7532 7.3346 8.4725 3.2572 6.1488 -24.49%
2000 7.5583 3.2455 15.3393 2.7899 8.1435 148.23%
1999 1.2804 1.1426 3.4095 0.6299 3.2806 202.64%
1998 1.3250 1.8807 2.1676 0.7850 1.0840 -41.64%
1997 1.6703 1.5934 2.3963 1.1777 1.8573 8.58%
1996 1.1151 1.0662 1.7692 0.6561 1.7106 57.80%
1995 0.8656 0.7499 1.1660 0.6505 1.0840 46.86%
1994 0.9771 1.0896 1.3886 0.6561 0.7381 -35.05%
1993 0.6052 0.5451 1.2302 0.3046 1.1365 104.11%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.000B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $154.721B 9.45
GSK (GSK) United Kingdom $71.915B 9.49
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.215B 19.14
Ginkgo Bioworks Holdings (DNA) United States $4.249B 0.00
Myovant Sciences (MYOV) United Kingdom $2.615B 0.00
Arcus Biosciences (RCUS) United States $1.532B 23.00
Biohaven (BHVN) United States $1.307B 0.00
Emergent Biosolutions (EBS) United States $0.726B 5.71
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Ambrx Biopharma (AMAM) United States $0.071B 0.00
Enzo Biochem (ENZ) United States $0.067B 0.00
SQZ Biotechnologies (SQZ) United States $0.023B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00